Joëlle Thonnard

841 total citations
16 papers, 520 citations indexed

About

Joëlle Thonnard is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Joëlle Thonnard has authored 16 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Joëlle Thonnard's work include T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Joëlle Thonnard is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Joëlle Thonnard collaborates with scholars based in Belgium, United Kingdom and Netherlands. Joëlle Thonnard's co-authors include Pierre G. Coulie, Thierry Boon, Didier Colau, Francesca Schiavetti, Rita Chiari, Jean‐François Baurain, P. Weynants, Katharina Fleischhauer, Jean Herman and Pierre van der Bruggen and has published in prestigious journals such as Hepatology, American Journal of Respiratory and Critical Care Medicine and Clinical Chemistry.

In The Last Decade

Joëlle Thonnard

15 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joëlle Thonnard Belgium	10	339	250	158	90	40	16	520
D. Rahman United Kingdom	5	181 0.5×	316 1.3×	76 0.5×	41 0.5×	93 2.3×	5	546
Nicole Lévy Switzerland	7	334 1.0×	217 0.9×	151 1.0×	22 0.2×	59 1.5×	9	511
Cristina L. Swanson United States	6	199 0.6×	285 1.1×	43 0.3×	60 0.7×	31 0.8×	7	509
Michelle Brault United States	7	173 0.5×	314 1.3×	83 0.5×	27 0.3×	52 1.3×	8	430
Allysia J. Matthews United States	5	253 0.7×	242 1.0×	79 0.5×	27 0.3×	24 0.6×	9	439
Lyse Santoro France	6	110 0.3×	186 0.7×	48 0.3×	96 1.1×	158 4.0×	7	368
Masashi Kurimoto Japan	9	299 0.9×	228 0.9×	52 0.3×	14 0.2×	70 1.8×	10	520
Maria Shnyreva United States	9	478 1.4×	484 1.9×	97 0.6×	24 0.3×	58 1.4×	10	892
Beth McInnes Canada	13	162 0.5×	194 0.8×	83 0.5×	14 0.2×	41 1.0×	15	411

Countries citing papers authored by Joëlle Thonnard

Since Specialization

Citations

This map shows the geographic impact of Joëlle Thonnard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joëlle Thonnard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joëlle Thonnard more than expected).

Fields of papers citing papers by Joëlle Thonnard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joëlle Thonnard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joëlle Thonnard. The network helps show where Joëlle Thonnard may publish in the future.

Co-authorship network of co-authors of Joëlle Thonnard

This figure shows the co-authorship network connecting the top 25 collaborators of Joëlle Thonnard. A scholar is included among the top collaborators of Joëlle Thonnard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joëlle Thonnard. Joëlle Thonnard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cheeseman, Sue, et al.. (2025). Establishing standards: harmonising coding principles for a minimal cancer dataset in the OMOP Common Data Model. PubMed. 9. 100179–100179. 1 indexed citations

Wijsenbeek, Marlies, Joëlle Thonnard, Ann Fieuw, et al.. (2018). Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries. OA263–OA263. 1 indexed citations

Gellynck, Kris, Mustapha Najimi, Catherine Lombard, et al.. (2016). Clinical-grade human liver mesenchymal stem cells for the treatment of NASH-Fibrosis through immunomodulation. Hepatology. 64. 1 indexed citations

Ballester, Alfredo, María Garcés‐Sánchez, Mamadou Dramé, et al.. (2010). PEDIATRIC SAFETY EVALUATION OF AN AS-ADJUVANTED H5N1 PREPANDEMIC CANDIDATE VACCINE IN CHILDREN AGED 6-9 YEARS. A PHASE II STUDY.

Sacarlal, Jahit, John J. Aponte, Pedro Aíde, et al.. (2007). Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial. Vaccine. 26(2). 174–184. 22 indexed citations

Schiavetti, Francesca, Joëlle Thonnard, Didier Colau, Thierry Boon, & Pierre G. Coulie. (2002). A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.. PubMed. 62(19). 5510–6. 158 indexed citations

Karanikas, Vaios, Didier Colau, Jean‐François Baurain, et al.. (2001). High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival.. PubMed. 61(9). 3718–24. 96 indexed citations

Weynants, P., Joëlle Thonnard, Marie Marchand, et al.. (1999). Derivation of Tumor-specific Cytolytic T-Cell Clones from Two Lung Cancer Patients with Long Survival. American Journal of Respiratory and Critical Care Medicine. 159(1). 55–62. 32 indexed citations

Chiari, Rita, F. Foury, Etienne De Plaen, et al.. (1999). Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.. PubMed. 59(22). 5785–92. 59 indexed citations

10.

Delmée, Michel & Joëlle Thonnard. (1997). Clostridium difficile toxin A detection on colonies. Clinical Microbiology and Infection. 3(3). 389–390. 2 indexed citations

11.

Thonnard, Joëlle, et al.. (1997). A new silent mutation at codon 35 in exon 2 yielding DRB1*04012 allele. Tissue Antigens. 49(3). 274–276. 4 indexed citations

12.

Thonnard, Joëlle, et al.. (1996). Toxin A detection on Clostridium difficile colonies from 24-h cultures. Clinical Microbiology and Infection. 2(1). 50–54. 13 indexed citations

13.

Herman, Jean, Pierre van der Bruggen, Immanuel F. Luescher, et al.. (1996). A peptide encoded by the human MAGE3 gene and presented by HLA-1344 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics. 43(6). 377–383. 87 indexed citations

14.

Thonnard, Joëlle, Philippe Moulin, Naïma Deggouj, et al.. (1996). HLA Class II-Associated Genetic Susceptibility in Idiopathic Progressive Sensorineural Hearing Loss. Annals of Otology Rhinology & Laryngology. 105(8). 628–633. 18 indexed citations

15.

Thonnard, Joëlle, et al.. (1995). A new HLA‐DRB1*1116 allele sharing DR13 and DR11 sequence motifs. Tissue Antigens. 46(2). 124–127. 10 indexed citations

16.

Thonnard, Joëlle, et al.. (1995). HLA class II genotyping: two assay systems compared. Clinical Chemistry. 41(4). 553–556. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact